CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)	Total	Common Stock	Additional Paid in Capital	Retained Earnings/Accumulated (Deficit)
Beginning Balances at Dec. 31, 2020	$ 40,038,891	$ 93,431	$ 40,455,409	$ (509,949)
Beginning Balance, shares at Dec. 31, 2020		9,343,118
Restricted stock grants issued		$ 635	(635)
Restricted stock grants issued, Shares		63,475
Stock-based compensation	31,706		31,706
Net income	411,247			411,247
Dividends	(607,303)			(607,303)
Ending Balance at Mar. 31, 2021	39,874,541	$ 94,066	40,486,480	(706,005)
Ending Balance, shares at Mar. 31, 2021		9,406,593
Beginning Balances at Dec. 31, 2021	$ 47,118,097	$ 107,086	46,851,360	159,651
Beginning Balance, shares at Dec. 31, 2021	10,708,613	10,708,613
Restricted stock grants issued		$ 260	(260)
Restricted stock grants issued, Shares		26,025
Restricted stock grant forfeitures, shares		(203)
Restricted stock grant forfeiture		$ (2)	2
Issuance of common stock, net of expenses	$ 198,370	$ 659	197,711
Issuance of common stock, net of expenses, Shares		65,843
Stock-based compensation	52,604		52,604
Net income	283,207			283,207
Dividends	(700,339)			(700,339)
Ending Balance at Mar. 31, 2022	$ 46,951,939	$ 108,003	$ 47,101,417	$ (257,481)
Ending Balance, shares at Mar. 31, 2022	10,800,278	10,800,278